TY - JOUR
T1 - Selective laser trabeculoplasty in uncontrolled pseudoexfoliation glaucoma
AU - Goldenfeld, Modi
AU - Geyer, Orna
AU - Segev, Eitan
AU - Kaplan-Messas, Audrey
AU - Melamed, Shlomo
PY - 2011/9
Y1 - 2011/9
N2 - ■ BACKGROUND AND OBJECTIVE: To assess the efficacy and safety of selective laser trabeculoplasty (SLT) in uncontrolled pseudoexfoliation glaucoma (PEXG). ■ PATIENTS AND METHODS: Fifty-seven eyes (57 patients) with uncontrolled PEXG and intraocular pressure (IOP) greater than 23 mm Hg underwent SLT. All received ophthalmic evaluation preoperatively and at intervals postoperatively. IOP was measured at 1 hour, 1 day, 1 week, and 1, 3, 6, and 12 months postoperatively. During follow-up, patients were treated with topical anti-glaucoma medications as necessary. ■ RESULTS: One year postoperatively, mean IOP in all patients decreased from 26.01 ± 2.5 to 17.8 ± 2.8 mm Hg (31.5%; P < .001). Mean medications per patient decreased from 2.8 to 2.3. Complications included conjunctival redness and infection within 1 day postoperatively in 30 eyes (67%). One hour after SLT treatment, an increase in IOP greater than 5 mm Hg was detected in two eyes (3.5%) and resolved within 24 hours with topical medication. ■ CONCLUSION: SLT is safe and effective in patients with PEXG.
AB - ■ BACKGROUND AND OBJECTIVE: To assess the efficacy and safety of selective laser trabeculoplasty (SLT) in uncontrolled pseudoexfoliation glaucoma (PEXG). ■ PATIENTS AND METHODS: Fifty-seven eyes (57 patients) with uncontrolled PEXG and intraocular pressure (IOP) greater than 23 mm Hg underwent SLT. All received ophthalmic evaluation preoperatively and at intervals postoperatively. IOP was measured at 1 hour, 1 day, 1 week, and 1, 3, 6, and 12 months postoperatively. During follow-up, patients were treated with topical anti-glaucoma medications as necessary. ■ RESULTS: One year postoperatively, mean IOP in all patients decreased from 26.01 ± 2.5 to 17.8 ± 2.8 mm Hg (31.5%; P < .001). Mean medications per patient decreased from 2.8 to 2.3. Complications included conjunctival redness and infection within 1 day postoperatively in 30 eyes (67%). One hour after SLT treatment, an increase in IOP greater than 5 mm Hg was detected in two eyes (3.5%) and resolved within 24 hours with topical medication. ■ CONCLUSION: SLT is safe and effective in patients with PEXG.
UR - http://www.scopus.com/inward/record.url?scp=80053199118&partnerID=8YFLogxK
U2 - 10.3928/15428877-20110630-01
DO - 10.3928/15428877-20110630-01
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:80053199118
SN - 1542-8877
VL - 42
SP - 390
EP - 393
JO - Ophthalmic Surgery Lasers and Imaging
JF - Ophthalmic Surgery Lasers and Imaging
IS - 5
ER -